Low-Energy Large-Spot Pico-lasergids: veilige huidbehandeling voor elk huidtype

Figuur-1.-Voor-en-na-vergelijking-van-LFHSS-1064-nm-nanoseconde-laserbehandeling-voor-melasma-a-voor-behandeling-b-na-behandeling.png

Ensuring optimal treatment outcomes while minimizing adverse reactions has always been a central challenge in medical aesthetics. Traditional high-fluence laser protocols are effective but frequently associated with complications such as post-inflammatory hyperpigmentation (PIH) and barrier disruption—especially in melanin-rich Asian skin types.

Low-Fluence, High-Spot-Size (LFHSS) laser technology offers a safer alternative by combining gentle thermal effects met precise pigment targeting. Today, this technique is widely applied in 1064 nm / 755 nm, nanoseconde En picoseconde platforms.

This article provides a comprehensive scientific and clinical overview of LFHSS: its origin, standardized definition, indication-specific parameters, treatment precautions, and contraindications—offering physicians a structured and evidence-based protocol.


1. Origin and Standard Definition

1.1 Historical Background

LFHSS can be traced back to the mid-2000s, when Korean dermatologists first applied large spot sizes and low fluence met Q-switched Nd:YAG 1064 nm nanosecond lasers for melasma management—coining the term Laser Toning.

The approach quickly gained global popularity and later inspired technologies such as “Whitening Toning,” “Carbon Peeling,” and other low-fluence programs.

With device evolution, LFHSS expanded to 755 nm nanosecond and picosecond lasers, enabling more precise pigment-selective treatment and significantly reduced risk of complications.


1.2 Standard Definition of LFHSS

LFHSS must meet all of the following technical criteria:

ParameterStandard Requirement
Vlekgrootte≥ 6 mm
Fluence≤ 3 J/cm²
Treatment EndpointMild warming or slight erythema

Wavelength Characteristics

  • 1064 nm → deeper penetration; targets dermal pigment (melasma, Hori’s nevus, PIH)
  • 755 nm → higher melanin absorption; ideal for epidermal pigment (freckles, epidermal melasma)

Pulsduur

  • Picosecond → photomechanical pigment fragmentation + skin rejuvenation
  • Nanosecond → epidermal/dermal modulation and skin conditioning

2.1 Pigmentary Disorders

(1) Melasma – 1064 nm Nanosecond Laser as Standard of Care

Recommended Parameters

  • Spot size: 6–8 mm
  • Fluence: 1–3 J/cm²
  • Frequentie: 5–10 Hz
  • Interval: every 2–4 weeks
  • Total sessions: ≤ 15 sessions
    (Exceeding 15 sessions increases risk of mottled hypopigmentation.)

Mechanisme:
LFHSS applies “subcellular selective photothermolysis”—breaking melanosomes while preserving melanocyte viability, thereby reducing PIH and rebound pigmentation.


Figuur-1.-Voor-en-na-vergelijking-van-LFHSS-1064-nm-nanoseconde-laserbehandeling-voor-melasma-a-voor-behandeling-b-na-behandeling.png
Figure 1. Before-and-after comparison of LFHSS 1064 nm nanosecond laser treatment for melasma (a before treatment, b after treatment).

(2) Hori’s Nevus / Dermal Melanocytosis

First choice:
755 nm picosecond laser
→ stronger photomechanical fragmentation
→ lower risk of PIH

If using a 1064 nm nanosecond device:

  • Spot size: 6–8 mm
  • Fluence: 1–3 J/cm²
  • Frequentie: 5–10 Hz
  • Interval: 2-4 weken
Figure-2.-Before-and-after-comparison-of-LFHSS-1064-nm-laser-treatment-for-Horis-nevus-dermal-melanocytosis
vFigure 2. Before-and-after comparison of LFHSS 1064 nm laser treatment for Hori’s nevus (dermal melanocytosis).

2.2 Inflammatory & Degenerative Skin Conditions

(1) Rosacea & Steroid-Induced Dermatitis

Recommended (1064 nm nanosecond “toning mode”)

  • Spot size: 6–8 mm
  • Fluence: 0.3–1.5 J/cm²
  • Interval: 4 weeks

Mechanisms:

  • Modulates vascular reactivity
  • Reduces inflammatory cytokines
  • Accelerates barrier repair
  • Improves flushing and sensitivity

(2) Skin Rejuvenation (755 nm Picosecond + MLA Technology)

Recommended Parameters

  • Spot size: 6–8 mm
  • Fluence: 0.5–1.0 J/cm²
  • Frequentie: 5–10 Hz
  • Interval: every 4 weeks

Voordelen:

  • Collagen neogenesis
  • Texture and pore refinement
  • Fine lines reduction
  • Minimale downtime
Figure-3.-Picosecond-fractional-laser-for-facial-rejuvenation-1A-before-treatment-1B-one-month-after-three-treatment-sessions
Figure 3. Picosecond fractional laser for facial rejuvenation (1A before treatment; 1B one month after three treatment sessions).

3. Treatment Precautions

3.1 Patch Test Protocol (Mandatory Step)

  1. Start with 1 J/cm², deliver 1–2 shots, observe for 5 minutes
    • If purplish erythema or pain → decrease fluence by 0.2–0.5 J/cm²
    • If minimal reaction → increase by 0.2–0.5 J/cm² (not exceeding 3 J/cm²)
  2. During full-face treatment, ensure the skin temperature stays below 40°C after 2–3 passes.

3.2 Preventing Excess Energy Accumulation

  • Overlap rate: ≤ 10%
  • Melasma: do not exceed 15 lifetime sessions
  • Periocular & perioral areas: reduce fluence by 20%
  • Always enable device cooling
    (air cooling / contact cooling / cryogen depending on device)

4. Contraindications

4.1 High-Vascular-Density Lesions (Port-Wine Stain, Hemangioma)

1064/755 nm wavelengths have low hemoglobin absorption
LFHSS fluence is insufficient to coagulate vessels →
May worsen vascular proliferation → Contraindicated


4.2 High-Density Tattoo Pigment

LFHSS fluence cannot reach the “instantaneous pigment explosion threshold” needed for tattoo removal.

  • Leads to inadequate fragmentation
  • Requires excessive sessions
  • Increases inflammation and PIH

→ Use high-fluence Q-switched or picosecond protocols instead.


4.3 Hyperkeratotic Lesions (Seborrheic Keratosis, Warts)

LFHSS is niet-ablatief and relies mainly on photobiomodulation →
Cannot vaporize keratin →
May stimulate further hyperkeratosis → Contraindicated


Conclusie

LFHSS technology, based on large spot size and low fluence, provides a safer, gentler laser strategy across multiple wavelengths and pulse modes. It offers significant benefits in:

  • Pigmentary disorders
  • Inflammatory skin conditions
  • Huidverjonging
  • Sensitive-skin management

However, clinicians should note:

  • Clear clinical consensus currently exists only for melasma
  • 15 sessions increases risk of mottled hypopigmentation
  • Evidence for rosacea and rejuvenation requires more long-term RCTs
  • Contraindications must be strictly followed

Future studies—especially multicenter randomized controlled trials—are essential to further define LFHSS treatment boundaries, optimize parameters, and elevate safety standards across medical aesthetic practice.

Meer gerelateerde blogs

Waarom CO₂ fractionele laser de genezing van tattoo-verwijdering helpt

Wat is Q-Switch en Yag Lasers voor professionele huidverzorging?

Q-Switched ND: YAG-laser voor gepigmenteerde laesies: behandelen van melasma, sproeten en moedervlekken

Hoe effectief is de Q-Switched ND: YAG Laser voor de behandeling van melasma?

Q-Switched Pico Laser: de complete gids voor mechanisme, behandelbereik & Veiligheidsopmerkingen

Pico-laser versus CO₂-laser: wat is beter voor het verwijderen van tatoeages?

Fractionele CO₂ + PicoWay: een praktische, inkomstengenererende combinatie voor diepere resurfacing & pigmentcontrole

Klinische gids voor Pico-laser volgens huideindpuntreacties: Optimaliseer Pico & Nanoseconde laserprestaties

Q-geschakelde laser: mechanisme, indicaties, contra-indicaties, parameters & Voorzorgsmaatregelen

Q-schakelaar laserhersteltijd: wat te verwachten en hoe de genezing te versnellen

Draagbare Picoway picoseconde machinebediening

Wat is de beste lasermachine voor het verwijderen van professionele tatoeage in 2025?

Prachtig! Deel dit artikel

Over de auteur

Ella van Mico Aes

Ella Chan

Welkom op mijn blogkanaal, waar ik meer dan 10 jaar expertise in de schoonheidsmachine-industrie breng. Van salonmachines tot schoonheidsapparaten voor thuisgebruik, ik begeleid u door de nieuwste ontwikkelingen, geef betrouwbare informatie en help u weloverwogen beslissingen te nemen. Ga met mij mee op deze transformatieve reis om je ware schoonheidspotentieel te ontsluiten met de kracht van technologie.

Bekijk meer producten

Over Mico Aes

mico aes-logo-3

Mico Aes is al meer dan 15 jaar een professionele fabrikant van schoonheidsmachines in China. We hebben alle soorten machines voor medische spa-, IPL- en laserontharingsmachines, hifu-machines, emsculptingmachines, cryolipolyse-machines, pico-lasermachines, rf-machines, cavitatiemachines , hydro-gezichtsmachines en apparaten voor led-lichttherapie en enkele schoonheidsapparaten voor persoonlijk gebruik. Meer details, of Neem contact met ons op.

Winkelwagen
Scroll naar boven